Niemann-Pick Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
Condition: Niemann-Pick Disease, Type C Intervention: Drug: 2-Hydroxypropyl-Beta-Cyclodextrin Sponsors: Washington University School of Medicine; Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2018 Category: Research Source Type: clinical trials

CTD Holdings Announces First Patient Dosed in Phase I/II Clinical Trial to Evaluate Trappsol ® Cyclo™ in Niemann-Pick Disease Type C
ALACHUA, FL -- (Marketwired) -- 07/19/17 -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing cyclodextrin-based products for the treatment of disease, today announced that the first patient has been dosed... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 19, 2017 Category: Pharmaceuticals Source Type: clinical trials

Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1 Intervention: Drug: Lithium Carbonate Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2017 Category: Research Source Type: clinical trials